{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T07:59:49Z","timestamp":1787990389293,"version":"build-2784847793"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,24]],"date-time":"2026-01-24T00:00:00Z","timestamp":1769212800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T00:00:00Z","timestamp":1770854400000},"content-version":"vor","delay-in-days":19,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001322","name":"South African Medical Research Council","doi-asserted-by":"crossref","award":["NA"],"award-info":[{"award-number":["NA"]}],"id":[{"id":"10.13039\/501100001322","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-36504-3","type":"journal-article","created":{"date-parts":[[2026,1,24]],"date-time":"2026-01-24T05:14:24Z","timestamp":1769231664000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Differences in red blood cell fatty acid profiles by type 2 diabetes status in early-stage chronic kidney disease"],"prefix":"10.1038","volume":"16","author":[{"given":"Cindy","family":"George","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jillian","family":"Hill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N. Unati","family":"Nqebelele","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dipuo D.","family":"Motshwari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nasheeta","family":"Peer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andre P.","family":"Kengne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul J.","family":"van Jaarsveld","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,24]]},"reference":[{"key":"36504_CR1","doi-asserted-by":"publisher","first-page":"1803","DOI":"10.1093\/ndt\/gfz174","volume":"34","author":"KJ Jager","year":"2019","unstructured":"Jager, K. J. et al. A single number for advocacy and communication-worldwide more than 850 million individuals have kidney diseases. Nephrol. Dial Transpl. 34, 1803\u20131805. https:\/\/doi.org\/10.1093\/ndt\/gfz174 (2019).","journal-title":"Nephrol. Dial Transpl."},{"key":"36504_CR2","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1016\/S0140-6736(20)30045-3","volume":"395","author":"Global Burden of Diseases Chronic Kidney Disease Collaboration","year":"2020","unstructured":"Global Burden of Diseases Chronic Kidney Disease Collaboration. Global, regional, and National burden of chronic kidney disease, 1990\u20132017: a systematic analysis for the global burden of disease study 2017. Lancet 395, 709\u2013733. https:\/\/doi.org\/10.1016\/S0140-6736(20)30045-3 (2020).","journal-title":"Lancet"},{"key":"36504_CR3","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1016\/S0140-6736(13)60687-X","volume":"382","author":"V Jha","year":"2013","unstructured":"Jha, V. et al. Chronic kidney disease: global dimension and perspectives. Lancet 382, 260\u2013272. https:\/\/doi.org\/10.1016\/S0140-6736(13)60687-X (2013).","journal-title":"Lancet"},{"key":"36504_CR4","doi-asserted-by":"publisher","first-page":"1068","DOI":"10.1016\/S0140-6736(13)62154-6","volume":"383","author":"SE Kahn","year":"2014","unstructured":"Kahn, S. E., Cooper, M. E. & Del Prato, S. Pathophysiology and treatment of type 2 diabetes: perspectives on the past, present, and future. Lancet 383, 1068\u20131083. https:\/\/doi.org\/10.1016\/S0140-6736(13)62154-6 (2014).","journal-title":"Lancet"},{"key":"36504_CR5","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1159\/000321845","volume":"31","author":"ND Vaziri","year":"2011","unstructured":"Vaziri, N. D. & Norris, K. Lipid disorders and their relevance to outcomes in chronic kidney disease. Blood Purif. 31, 189\u2013196. https:\/\/doi.org\/10.1159\/000321845 (2011).","journal-title":"Blood Purif."},{"key":"36504_CR6","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1159\/000144024","volume":"28","author":"V Tsimihodimos","year":"2008","unstructured":"Tsimihodimos, V., Dounousi, E. & Siamopoulos, K. C. Dyslipidemia in chronic kidney disease: an approach to pathogenesis and treatment. Am. J. Nephrol. 28, 958\u2013973. https:\/\/doi.org\/10.1159\/000144024 (2008).","journal-title":"Am. J. Nephrol."},{"key":"36504_CR7","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1194\/jlr.P040501","volume":"55","author":"M Herman-Edelstein","year":"2014","unstructured":"Herman-Edelstein, M., Scherzer, P., Tobar, A., Levi, M. & Gafter, U. Altered renal lipid metabolism and renal lipid accumulation in human diabetic nephropathy. J. Lipid Res. 55, 561\u2013572. https:\/\/doi.org\/10.1194\/jlr.P040501 (2014).","journal-title":"J. Lipid Res."},{"key":"36504_CR8","doi-asserted-by":"publisher","first-page":"1496","DOI":"10.2337\/diacare.27.6.1496","volume":"27","author":"RM Krauss","year":"2004","unstructured":"Krauss, R. M. Lipids and lipoproteins in patients with type 2 diabetes. Diabetes Care. 27, 1496\u20131504. https:\/\/doi.org\/10.2337\/diacare.27.6.1496 (2004).","journal-title":"Diabetes Care"},{"key":"36504_CR9","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1007\/s11745-003-1068-y","volume":"38","author":"PC Calder","year":"2003","unstructured":"Calder, P. C. N-3 polyunsaturated fatty acids and inflammation: from molecular biology to the clinic. Lipids 38, 343\u2013352. https:\/\/doi.org\/10.1007\/s11745-003-1068-y (2003).","journal-title":"Lipids"},{"key":"36504_CR10","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1093\/ajcn\/nqy089","volume":"108","author":"JT Brenna","year":"2018","unstructured":"Brenna, J. T., Plourde, M., Stark, K. D., Jones, P. J. & Lin, Y. H. Best practices for the design, laboratory analysis, and reporting of trials involving fatty acids. Am. J. Clin. Nutr. 108, 211\u2013227. https:\/\/doi.org\/10.1093\/ajcn\/nqy089 (2018).","journal-title":"Am. J. Clin. Nutr."},{"key":"36504_CR11","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1093\/ajcn\/45.2.443","volume":"45","author":"RM Dougherty","year":"1987","unstructured":"Dougherty, R. M., Galli, C., Ferro-Luzzi, A. & Iacono, J. M. Lipid and phospholipid fatty acid composition of plasma, red blood cells, and platelets and how they are affected by dietary lipids: a study of normal subjects from Italy, Finland, and the USA. Am. J. Clin. Nutr. 45, 443\u2013455. https:\/\/doi.org\/10.1093\/ajcn\/45.2.443 (1987).","journal-title":"Am. J. Clin. Nutr."},{"key":"36504_CR12","doi-asserted-by":"publisher","unstructured":"Hill, J. et al. Findings from Community-Based screenings for type 2 diabetes mellitus in at risk communities in cape Town, South africa: A pilot study. Int. J. Environ. Res. Public Health. 17 https:\/\/doi.org\/10.3390\/ijerph17082876 (2020).","DOI":"10.3390\/ijerph17082876"},{"key":"36504_CR13","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.diabres.2012.10.018","volume":"99","author":"TE Matsha","year":"2013","unstructured":"Matsha, T. E. et al. Three-year\u2019s changes in glucose tolerance status in the Bellville South cohort: rates and phenotypes associated with progression. Diabetes Res. Clin. Pract. 99, 223\u2013230. https:\/\/doi.org\/10.1016\/j.diabres.2012.10.018 (2013).","journal-title":"Diabetes Res. Clin. Pract."},{"key":"36504_CR14","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1136\/bmj.39063.689375.55","volume":"334","author":"CL Gillies","year":"2007","unstructured":"Gillies, C. L. et al. Pharmacological and lifestyle interventions to prevent or delay type 2 diabetes in people with impaired glucose tolerance: systematic review and meta-analysis. BMJ (Clinical Res. ed.). 334, 299. https:\/\/doi.org\/10.1136\/bmj.39063.689375.55 (2007).","journal-title":"BMJ (Clinical Res. ed.)"},{"key":"36504_CR15","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1016\/j.cct.2005.01.002","volume":"26","author":"DR Parker","year":"2005","unstructured":"Parker, D. R., Evangelou, E. & Eaton, C. B. Intraclass correlation coefficients for cluster randomized trials in primary care: the cholesterol education and research trial (CEART). Contemp. Clin. Trials. 26, 260\u2013267. https:\/\/doi.org\/10.1016\/j.cct.2005.01.002 (2005).","journal-title":"Contemp. Clin. Trials"},{"key":"36504_CR16","unstructured":"Mayige, M. Derivation and Validation of a Simple Risk Score for Undiagnosed Diabetes for Tanzania and Other African Populations. PhD thesis, Newcastle University, (2014)."},{"key":"36504_CR17","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1186\/s12902-024-01735-w","volume":"24","author":"N Royce","year":"2024","unstructured":"Royce, N. et al. HbA1c comparable to fasting glucose in the external validation of the African diabetes risk score and other established risk prediction models in black South Africans. BMC Endocr. Disord. 24, 213. https:\/\/doi.org\/10.1186\/s12902-024-01735-w (2024).","journal-title":"BMC Endocr. Disord"},{"key":"36504_CR18","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1111\/j.1464-5491.2006.01858.x","volume":"23","author":"KG Alberti","year":"2006","unstructured":"Alberti, K. G., Zimmet, P. & Shaw, J. Metabolic syndrome\u2013a new world-wide definition. A consensus statement from the international diabetes federation. Diabet. Medicine: J. Br. Diabet. Association. 23, 469\u2013480. https:\/\/doi.org\/10.1111\/j.1464-5491.2006.01858.x (2006).","journal-title":"Diabet. Medicine: J. Br. Diabet. Association"},{"key":"36504_CR19","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1002\/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S","volume":"15","author":"KG Alberti","year":"1998","unstructured":"Alberti, K. G. & Zimmet, P. Z. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet. Medicine: J. Br. Diabet. Association. 15, 539\u2013553. https:\/\/doi.org\/10.1002\/(SICI)1096-9136(199807)15:7%3C539::AID-DIA668%3E3.0.CO;2-S (1998).","journal-title":"Diabet. Medicine: J. Br. Diabet. Association"},{"key":"36504_CR20","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1093\/clinchem\/18.6.499","volume":"18","author":"WT Friedewald","year":"1972","unstructured":"Friedewald, W. T., Levy, R. I. & Fredrickson, D. S. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin. Chem. 18, 499\u2013502 (1972).","journal-title":"Clin. Chem."},{"key":"36504_CR21","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/S0021-9258(18)64849-5","volume":"226","author":"J Folch","year":"1957","unstructured":"Folch, J., Lees, M. & Sloane Stanley, G. H. A simple method for the isolation and purification of total lipides from animal tissues. J. Biol. Chem. 226, 497\u2013509 (1957).","journal-title":"J. Biol. Chem."},{"key":"36504_CR22","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1017\/S000711451700366X","volume":"119","author":"T Chimhashu","year":"2018","unstructured":"Chimhashu, T. et al. Sensitivity of fatty acid desaturation and elongation to plasma zinc concentration: a randomised controlled trial in Beninese children. Br. J. Nutr. 119, 610\u2013619. https:\/\/doi.org\/10.1017\/S000711451700366X (2018).","journal-title":"Br. J. Nutr."},{"key":"36504_CR23","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1080\/21623945.2021.1979758","volume":"10","author":"I Mentoor","year":"2021","unstructured":"Mentoor, I., Engelbrecht, A. M., van de Vyver, M., van Jaarsveld, P. J. & Nell, T. The paracrine effects of adipocytes on lipid metabolism in doxorubicin-treated triple negative breast cancer cells. Adipocyte 10, 505\u2013523. https:\/\/doi.org\/10.1080\/21623945.2021.1979758 (2021).","journal-title":"Adipocyte"},{"key":"36504_CR24","doi-asserted-by":"publisher","first-page":"127","DOI":"10.3945\/ajcn.110.005447","volume":"93","author":"J Kroger","year":"2011","unstructured":"Kroger, J. et al. Erythrocyte membrane phospholipid fatty acids, desaturase activity, and dietary fatty acids in relation to risk of type 2 diabetes in the European prospective investigation into cancer and nutrition (EPIC)-Potsdam study. Am. J. Clin. Nutr. 93, 127\u2013142. https:\/\/doi.org\/10.3945\/ajcn.110.005447 (2011).","journal-title":"Am. J. Clin. Nutr."},{"key":"36504_CR25","doi-asserted-by":"publisher","first-page":"604","DOI":"10.7326\/0003-4819-150-9-200905050-00006","volume":"150","author":"AS Levey","year":"2009","unstructured":"Levey, A. S. et al. A new equation to estimate glomerular filtration rate. Ann. Intern. Med. 150, 604\u2013612. https:\/\/doi.org\/10.7326\/0003-4819-150-9-200905050-00006 (2009).","journal-title":"Ann. Intern. Med."},{"key":"36504_CR26","doi-asserted-by":"publisher","unstructured":"Kidney Disease. Improving global Outcomes. KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int. 3, 19\u201362. https:\/\/doi.org\/10.1038\/kisup.2012.64 (2013).","DOI":"10.1038\/kisup.2012.64"},{"key":"36504_CR27","doi-asserted-by":"publisher","unstructured":"Kidney Disease: Improving global Outcomes. KDIGO 2024 clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int. 105, S117\u2013S314. https:\/\/doi.org\/10.1016\/j.kint.2023.10.018 (2024).","DOI":"10.1016\/j.kint.2023.10.018"},{"key":"36504_CR28","unstructured":"World Health Organization. A global brief on Hypertension: Silent killer, global public health crisis. (2013)."},{"key":"36504_CR29","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1016\/j.clnu.2012.10.013","volume":"32","author":"A Diaz-Lopez","year":"2013","unstructured":"Diaz-Lopez, A. et al. Cross-sectional associations between macronutrient intake and chronic kidney disease in a population at high cardiovascular risk. Clin. Nutr. 32, 606\u2013612. https:\/\/doi.org\/10.1016\/j.clnu.2012.10.013 (2013).","journal-title":"Clin. Nutr."},{"key":"36504_CR30","doi-asserted-by":"publisher","first-page":"2275","DOI":"10.1210\/clinem\/dgaa173","volume":"105","author":"N Tofte","year":"2020","unstructured":"Tofte, N. et al. Plasma metabolomics identifies markers of impaired renal function: A Meta-analysis of 3089 persons with type 2 diabetes. J. Clin. Endocrinol. Metab. 105, 2275\u20132287. https:\/\/doi.org\/10.1210\/clinem\/dgaa173 (2020).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"36504_CR31","doi-asserted-by":"publisher","first-page":"1829","DOI":"10.1016\/j.clnu.2017.11.019","volume":"37","author":"ML Syren","year":"2018","unstructured":"Syren, M. L. et al. The polyunsaturated fatty acid balance in kidney health and disease: A review. Clin. Nutr. 37, 1829\u20131839. https:\/\/doi.org\/10.1016\/j.clnu.2017.11.019 (2018).","journal-title":"Clin. Nutr."},{"key":"36504_CR32","doi-asserted-by":"publisher","first-page":"e072909","DOI":"10.1136\/bmj-2022-072909","volume":"380","author":"KL Ong","year":"2023","unstructured":"Ong, K. L. et al. Association of Omega 3 polyunsaturated fatty acids with incident chronic kidney disease: pooled analysis of 19 cohorts. BMJ (Clinical Res. ed.). 380, e072909. https:\/\/doi.org\/10.1136\/bmj-2022-072909 (2023).","journal-title":"BMJ (Clinical Res. ed.)"},{"key":"36504_CR33","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1373\/clinchem.2007.095521","volume":"54","author":"F Lauretani","year":"2008","unstructured":"Lauretani, F. et al. Plasma polyunsaturated fatty acids and the decline of renal function. Clin. Chem. 54, 475\u2013481. https:\/\/doi.org\/10.1373\/clinchem.2007.095521 (2008).","journal-title":"Clin. Chem."},{"key":"36504_CR34","doi-asserted-by":"publisher","first-page":"112156","DOI":"10.1016\/j.nut.2023.112156","volume":"115","author":"A Hara","year":"2023","unstructured":"Hara, A. et al. Distinct associations between dietary omega-3 and omega-6 fatty acids intake with chronic kidney disease in adults with and without diabetes: A cross-sectional study. Nutr. (Burbank Los Angeles Cty. Calif). 115, 112156. https:\/\/doi.org\/10.1016\/j.nut.2023.112156 (2023).","journal-title":"Nutr. (Burbank Los Angeles Cty. Calif)"},{"key":"36504_CR35","doi-asserted-by":"publisher","first-page":"1454","DOI":"10.2337\/diacare.27.6.1454","volume":"27","author":"C Cardenas","year":"2004","unstructured":"Cardenas, C. et al. Polyunsaturated fatty acid consumption May play a role in the onset and regression of microalbuminuria in well-controlled type 1 and type 2 diabetic people: a 7-year, prospective, population-based, observational multicenter study. Diabetes Care. 27, 1454\u20131457. https:\/\/doi.org\/10.2337\/diacare.27.6.1454 (2004).","journal-title":"Diabetes Care"},{"key":"36504_CR36","doi-asserted-by":"publisher","first-page":"e0195249","DOI":"10.1371\/journal.pone.0195249","volume":"13","author":"ALT Dos Santos","year":"2018","unstructured":"Dos Santos, A. L. T. et al. Low linolenic and Linoleic acid consumption are associated with chronic kidney disease in patients with type 2 diabetes. PloS One. 13, e0195249. https:\/\/doi.org\/10.1371\/journal.pone.0195249 (2018).","journal-title":"PloS One"},{"key":"36504_CR37","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1007\/s00125-024-06108-5","volume":"67","author":"Q Jin","year":"2024","unstructured":"Jin, Q. et al. Circulating metabolomic markers linking diabetic kidney disease and incident cardiovascular disease in type 2 diabetes: analyses from the Hong Kong diabetes biobank. Diabetologia 67, 837\u2013849. https:\/\/doi.org\/10.1007\/s00125-024-06108-5 (2024).","journal-title":"Diabetologia"},{"key":"36504_CR38","doi-asserted-by":"publisher","first-page":"e0154683","DOI":"10.1371\/journal.pone.0154683","volume":"11","author":"E Han","year":"2016","unstructured":"Han, E. et al. Effects of Omega-3 fatty acid supplementation on diabetic nephropathy progression in patients with diabetes and hypertriglyceridemia. PloS One. 11, e0154683. https:\/\/doi.org\/10.1371\/journal.pone.0154683 (2016).","journal-title":"PloS One"},{"key":"36504_CR39","doi-asserted-by":"publisher","first-page":"e0228315","DOI":"10.1371\/journal.pone.0228315","volume":"15","author":"A Chewcharat","year":"2020","unstructured":"Chewcharat, A., Chewcharat, P., Rutirapong, A. & Papatheodorou, S. The effects of omega-3 fatty acids on diabetic nephropathy: A meta-analysis of randomized controlled trials. PloS One. 15, e0228315. https:\/\/doi.org\/10.1371\/journal.pone.0228315 (2020).","journal-title":"PloS One"},{"key":"36504_CR40","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1053\/j.ajkd.2010.03.009","volume":"56","author":"RG Fassett","year":"2010","unstructured":"Fassett, R. G., Gobe, G. C., Peake, J. M. & Coombes, J. S. Omega-3 polyunsaturated fatty acids in the treatment of kidney disease. Am. J. Kidney Dis. 56, 728\u2013742. https:\/\/doi.org\/10.1053\/j.ajkd.2010.03.009 (2010).","journal-title":"Am. J. Kidney Dis."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-36504-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-36504-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-36504-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T10:28:55Z","timestamp":1770892135000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-36504-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,24]]},"references-count":40,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["36504"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-36504-3","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,24]]},"assertion":[{"value":"1 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The study was conducted in accordance with the Declaration of Helsinki and approved by the Research Ethics Committee of the South African Medical Research Council (SAMRC) (approval no. EC018-7\/2015). All participants voluntary signed written informed consent after the procedures were fully explained in the language of their choice.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}],"article-number":"6127"}}